## Abstract The myeloproliferative disorders (MPDs) are chronic malignant conditions originating from the clonal expansion of a multipotential hematopoietic stem cell. These diseases include polycythemia vera (PV), essential thrombocythenia, atypical chronic myeloid leukemia, idiopathic hypereosino
Soluble angiogenic factors: Implications for chronic myeloproliferative disorders
โ Scribed by C. Musolino; L. Calabro'; G. Bellomo; F. Martello; B. Loteta; C. Pezzano; V. Rizzo; A. Alonci
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 128 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Patients with chronic myeloproliferative disorders (CMD) show a high frequency of thrombosis. For this reason we evaluated endothelial cell markers, soluble adhesion molecule E-selectin (sELAM), and thrombomodulin (TM) in 25 patients with CMD. Among them nine presented thromboses in their past histo
## Abstract The impact of cytogenetic characterization based on chromosome banding analyses and fluorescence in situ hybridization on clinical decision making has increased dramatically during recent years. Therefore, laboratory techniques have to be optimized to provide reliable results for optima